Last $0.75 USD
Change Today -0.0201 / -2.61%
Volume 39.8K
OXYS On Other Exchanges
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

oxysure systems inc (OXYS) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/20/14 - $1.40
52 Week Low
11/12/14 - $0.45
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OXYSURE SYSTEMS INC (OXYS)

Related News

No related news articles were found.

oxysure systems inc (OXYS) Related Businessweek News

No Related Businessweek News Found

oxysure systems inc (OXYS) Details

OxySure Systems, Inc., a medical technology company, is engaged in the design, manufacture, and distribution of respiratory and emergency medical solutions. It provides OxySure Model 615, a portable emergency oxygen system. The company also offers complimentary products and solutions, including display wall boxes, oxygen wall signage, resuscitation bags, pulse oximeters, and automated external defibrillators, as well as thermal bags and replacement cartridges for its OxySure Model 615. Its products enhance the access to emergency oxygen that affects the survival, recovery, and safety of individuals in various areas of need. The company sells its products to institutional customers through distributors, sub-distributors, and sales agents in the United States and internationally. OxySure Systems, Inc. was founded in 2004 and is headquartered in Frisco, Texas.

24 Employees
Last Reported Date: 04/15/14
Founded in 2004

oxysure systems inc (OXYS) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $115.0K
Compensation as of Fiscal Year 2013.

oxysure systems inc (OXYS) Key Developments

Oxysure Systems, Inc. Signs Distribution Agreement with HTM Medico Pte Ltd in Singapore

OxySure Systems, Inc. announced that it has signed an exclusive distribution agreement with HTM Medico Pte Ltd. in Singapore. The agreement appoints HTM Medico as the company's exclusive distributor in Singapore, and requires an annual minimum purchase commitment of 1,250 units of Model 615, valuing the contract at $1.3 million in the first 5 years.

OxySure Systems, Inc. Signs Distribution Agreement with Cardiac Life of Rochester

OxySure Systems, Inc. announced that the company has signed a distribution agreement with Cardiac Life of Rochester.

OxySure Systems, Inc. Announces Earnings Results for the Third Quarter and Sales Results Nine Months Ended September 30, 2014

OxySure Systems, Inc. announced earnings results for the third quarter and sales results nine months ended September 30, 2014. For the quarter, the company's revenues increased by 50% to $818,456 from $545,820 in the third quarter of 2013. The increase was primarily driven by an increase in US product sales and product sales related to military markets. Net loss was $462,349, or $0.02 per share as compared to $82,613 or $0.00 per share for the quarter ended September 30, 2013. EBITDA loss was $273,034. For the nine months, the company reported revenues of $1,852,796.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXYS:US $0.75 USD -0.0201

OXYS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OXYS.
View Industry Companies

Industry Analysis


Industry Average

Valuation OXYS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.2x
Price/Book 19.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OXYSURE SYSTEMS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at